Page last updated: 2024-09-04

bz-423 and Glomerulonephritis, Lupus

bz-423 has been researched along with Glomerulonephritis, Lupus in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bednarski, JJ; Ellman, JA; Glick, GD; Johnson, KJ; Leonetti, F; Opipari, AW; Rao, T; Richardson, BC; Warner, RE; Yung, R	1

Other Studies

1 other study(ies) available for bz-423 and Glomerulonephritis, Lupus

Article	Year
Attenuation of autoimmune disease in Fas-deficient mice by treatment with a cytotoxic benzodiazepine. Arthritis and rheumatism, 2003, Volume: 48, Issue:3 Topics: Adjuvants, Immunologic; Animals; Antibodies, Antinuclear; Benzodiazepines; Disease Models, Animal; Disease-Free Survival; fas Receptor; Female; Glomerulonephritis; Injections, Intraperitoneal; Kidney; Lupus Nephritis; Lymphocyte Activation; Mice; Mice, Inbred BALB C; Mice, Knockout; Survival Rate; T-Lymphocyte Subsets	2003

Article

Year

Attenuation of autoimmune disease in Fas-deficient mice by treatment with a cytotoxic benzodiazepine.

Arthritis and rheumatism, 2003, Volume: 48, Issue:3

Topics: Adjuvants, Immunologic; Animals; Antibodies, Antinuclear; Benzodiazepines; Disease Models, Animal; Disease-Free Survival; fas Receptor; Female; Glomerulonephritis; Injections, Intraperitoneal; Kidney; Lupus Nephritis; Lymphocyte Activation; Mice; Mice, Inbred BALB C; Mice, Knockout; Survival Rate; T-Lymphocyte Subsets

2003